CorpDev.Org
Daily News for Dealmakers
Big Deal
Bob Iger Just Got the Better of Sam Altman: Disney’s Strategic Win in AI Content Licensing
In a landmark move that underscores Disney’s strategic acumen under CEO Bob Iger, The Walt Disney Company has secured a pivotal licensing and investment deal with OpenAI, led by CEO Sam Altman. This agreement not only positions Disney as the...
Home Depot’s $5.5 Billion GMS Acquisition: Strategic Masterstroke in Pro Market Expansion
Home Depot's acquisition of GMS Inc. for $5.5 billion represents a transformative consolidation in the building products distribution sector, accelerating its penetration into the professional contractor market through subsidiary SRS Distribution....
Metro Bank’s Majority Shareholder Explores Stake Sale Amid Private Equity Interest
Colombian billionaire Jaime Gilinski Bacal, Metro Bank's controlling shareholder with a 52.87% stake, is actively exploring a sale of his position following unsolicited investor interest and a sustained share price recovery. This development comes...
Shell Denies BP Mega-Merger: Strategic Implications for the Energy Sector
Shell's swift denial of merger talks with BP marks a pivotal moment in energy sector consolidation, revealing deeper strategic realignments as oil giants navigate volatile markets. The proposed $80 billion acquisition would have created a $300...
Record M&A Insurance Payouts Signal Fundamental Shift in Transaction Risk Management
Aon's landmark Global Transaction Solutions Claims Study reveals unprecedented activity in representations and warranties (R&W) insurance, with North American clients recovering a record $300 million in paid claims during 2024 alone—the highest...
Explainers
Private Equity
International
International
Tech, Media & Telecom
Financial Services
Health & Life Sciences
Samsung Biologics’ $280M Acquisition of GSK’s Human Genome Sciences Marks Strategic U.S. Biomanufacturing Expansion
Samsung Biologics America (SBA), a wholly owned subsidiary of South Korea's leading contract development and manufacturing organization (CDMO), has agreed to acquire 100% of Human Genome Sciences (HGS) from GSK for $280 million, securing its first...
BioMarin to Acquire Amicus Therapeutics for $4.8 Billion — A Strategic Push to Tighten Rare‑Disease Leadership
BioMarin Pharmaceutical has agreed to acquire Amicus Therapeutics in an all‑cash deal valued at approximately $4.8 billion
Philips Bets On AI To See Inside Arteries With SpectraWAVE Buy
Royal Philips (NYSE: PHG), a global leader in medical technology, has agreed to acquire SpectraWAVE, Inc., a Massachusetts-based innovator in **AI-powered intravascular imaging**, to bolster its coronary intervention portfolio amid intensifying...
Nippon Life’s Strategic Leap: Pursuing a Medical‑data Platform in a Milestone Buy
Nippon Life Insurance Co. is pursuing an acquisition of a Japanese medical‑data firm, marking what executives describe as a strategic milestone as the insurer shifts from traditional asset allocation toward data‑driven health‑services...
Japanese Pharmas Expand Cross-Border M&A Footprint in US and EU Amid Domestic Market Stagnation
Japanese pharmaceutical companies are increasingly pursuing mergers and acquisitions (M&A) beyond their domestic borders, targeting strategic assets in the United States and Europe to drive growth and innovation. This shift reflects a broader...
